Clinical Trials Update: March 25, 2008
Gastroesophageal Reflux Disease (GERD)
Multiple Sclerosis
Healthy Patient Studies
|
E-mail this article
Subscribe to news
Printer friendly version
|
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Gastroesophageal Reflux Disease (GERD)
If you are 18 to 65, have nighttime heartburn with GERD-associated sleep disturbance, have been diagnosed with esophageal erosions for at least six months, and are willing to have screening procedures that may include endoscopy, you may qualify for this study.
The research site is in Nashville, Tenn.
More information
Please see http://www.centerwatch.com/patient/studies/cat70.html 
.
-----
Multiple Sclerosis
If you have relapsing MS, have a screening EDSS score below 6.0, have had at least one clinical relapse in the past 12 months, and have failed beta-interferon treatment, you may qualify for this study.
The research site is in Washington, D.C.
More information
Please see http://www.centerwatch.com/patient/studies/cat102.html .
-----
Healthy Patient Studies
If you are a healthy male or female aged 18 to 40, you may qualify for this outpatient study. No overnight stays are required.
The research site is in Daytona Beach, Fla.
More information
Please see http://www.centerwatch.com/patient/studies/phasei.html .
-----
Copyright 2008 Thomson CenterWatch . All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved. 
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.